Trademark: 97305795
Word
CELLE
Status Date
Wednesday, June 12, 2024
Filing Date
Thursday, March 10, 2022
Published for Opposition
Tuesday, July 11, 2023
40 Cryogenic preservation of umbilical cord stem cells, mesenchymal stem cells, menstrual stem cells, birth tissue, placentas and human tissue for medical, therapeutic, biotechnological, cosmetic and pharmaceutical use
5 Cell parts in the nature of exosomes for medical purposes; biological preparations comprising exosomes for the treatment of wounds, cancers and neurodegenerative, cardiovascular, hematological, inflammatory, autoimmune, pulmonary and orthopedic diseases; human blood for medical purposes; blood plasma; cord blood for medical purposes; stem cells for medical purposes
1 Biological preparations comprising exosomes for use in scientific research, industry and science; Biological preparations comprising exosomes for use in the manufacture of pharmaceuticals for treating wounds, cancers and neurodegenerative, cardiovascular, hematological, inflammatory, autoimmune, pulmonary and orthopedic diseases; human blood for scientific and medical research use; Cord blood for scientific and medical research use; Stem cells for research and scientific purposes
44 Medical services, namely, infusion therapy services; Medical services, namely, cord blood infusion services, stem cell infusion services; Medical services, namely, stem cell transplantation, stem cell therapy and stem cell treatment services; Blood, organ, and tissue bank services for human blood, human umbilical cord blood, human umbilical cord blood stem cells, mesenchymal stem cells, human menstrual stem cells, birth tissue, placentas and human tissue for medical, therapeutic, biotechnological, cosmetic and pharmaceutical use; collection and preservation of human blood, menstrual blood, and umbilical cord blood, for medical, therapeutic, biotechnological, cosmetic and pharmaceutical use; Collection of umbilical cord stem cells, mesenchymal stem cells, menstrual stem cells, birth tissue, placentas and human tissue for medical, therapeutic, biotechnological, cosmetic and pharmaceutical use
The English translation of the word "CELLE" in the mark is "THE ONE".
Mar 14, 2022
New Application Entered
Mar 15, 2022
New Application Office Supplied Data Entered
Aug 11, 2022
Assigned To Examiner
Aug 16, 2022
Non-Final Action Written
Aug 16, 2022
Non-Final Action E-Mailed
Aug 16, 2022
Notification Of Non-Final Action E-Mailed
Jan 26, 2023
Teas Response To Office Action Received
Jan 26, 2023
Correspondence Received In Law Office
Jan 26, 2023
Teas/Email Correspondence Entered
Feb 2, 2023
Examiners Amendment -Written
Feb 2, 2023
Examiners Amendment E-Mailed
Feb 2, 2023
Notification Of Examiners Amendment E-Mailed
Feb 2, 2023
Examiner's Amendment Entered
Mar 1, 2023
Non-Final Action Written
Mar 1, 2023
Non-Final Action E-Mailed
Mar 1, 2023
Notification Of Non-Final Action E-Mailed
Jun 1, 2023
Teas Response To Office Action Received
Jun 1, 2023
Correspondence Received In Law Office
Jun 2, 2023
Teas/Email Correspondence Entered
Jun 5, 2023
Examiners Amendment -Written
Jun 5, 2023
Examiners Amendment E-Mailed
Jun 5, 2023
Notification Of Examiners Amendment E-Mailed
Jun 5, 2023
Examiner's Amendment Entered
Jun 5, 2023
Approved For Pub - Principal Register
Jun 21, 2023
Notification Of Notice Of Publication E-Mailed
Jul 11, 2023
Published For Opposition
Jul 11, 2023
Official Gazette Publication Confirmation E-Mailed
Sep 5, 2023
Noa E-Mailed - Sou Required From Applicant
Mar 5, 2024
Sou Extension 1 Filed
Apr 8, 2024
Abandonment - No Use Statement Filed
Apr 8, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Apr 9, 2024
Notice Of Revival - E-Mailed
Apr 9, 2024
Petition To Revive-Granted
Apr 9, 2024
Teas Petition To Revive Received
Apr 9, 2024
Sou Extension Received With Teas Petition
Apr 9, 2024
Teas Petition To Revive Received
Jun 12, 2024
Case Assigned To Intent To Use Paralegal
Jun 13, 2024
Sou Extension 1 Granted
Jun 13, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
